Carmat SA provided sales guidance for the year 2024. For the period, the company expects Sales of ?14 Million to ?20 Million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.32 EUR | +6.14% | +43.52% | -35.52% |
05-06 | Carmat: progress in ongoing clinical study | CF |
05-06 | CARMAT Continues to Build on Its Momentum in the EFICAS Study | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.52% | 108M | |
+10.49% | 125B | |
-7.14% | 10.97B | |
+4.05% | 8.99B | |
+35.39% | 5.38B | |
-14.29% | 4.86B | |
+8.31% | 3.43B | |
-8.87% | 2.78B | |
-4.33% | 2.22B | |
-0.90% | 2.21B |
- Stock Market
- Equities
- ALCAR Stock
- News CARMAT
- Carmat Sa Provides Sales Guidance for the Year 2024